Louis Yu - Perrigo Company Executive Vice President - Global Quality

PRGO -- USA Stock  

USD 54.30  0.94  1.70%

  President
Dr. Louis W. Yu Ph.D., is Executive Executive Vice President Global Quality of the Company. He served as Senior Vice President, Global Quality from November 2006 to June 2013. Previously, Dr. Yu served from 2005 to October 2006 as Vice President, Quality at CV Therapeutics Inc. Prior to that position, he served as Global Head of Quality Compliance for Forest Laboratories, Inc. from 1999 to 2005. He served as the Vice President, Quality Compliance for Solvay Pharmaceuticals between 1996 and 1999. Currently, he is associated with the University of Wisconsin, serving as Adjunct Professor, Extension Services in Pharmacy, School of Pharmacy.
Age: 64  President Since 2013  Ph.D    
353 1 709 4000  http://www.perrigo.com

Management Efficiency

The company has return on total asset (ROA) of 2.34 % which means that it generated profit of $2.34 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 1.49 % meaning that it created $1.49 on every $100 dollars invested by stockholders.
The company currently holds 3.62B in liabilities with Debt to Equity (D/E) ratio of 63.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Perrigo Company has Current Ratio of 1.88 which is within standard range for the sector.

Similar Executives

Showing few of many executives

PRESIDENT Since

Cartikeya ReddyDr Reddys Laboratories Ltd
2016
Paul SilvaVertex Pharmaceuticals Incorpor
2019
Daniel PlewRegeneron Pharmaceuticals
2016
John GrayVertex Pharmaceuticals Incorpor
2019
Thomas GraneyVertex Pharmaceuticals Incorpor
2017
Stefan WeiskopfZoetis
2013
Charles WagnerVertex Pharmaceuticals Incorpor
2019
Sripada ChandrasekharDr Reddys Laboratories Ltd
2013
Jeffrey ChodakewitzVertex Pharmaceuticals Incorpor
2014
Sandra BeatyZoetis
2012
Alok SonigDr Reddys Laboratories Ltd
2015
Saumen ChakrabortyDr Reddys Laboratories Ltd
2018
Amit BiswasDr Reddys Laboratories Ltd
2016
K RaoDr Reddys Laboratories Ltd
2016
Ian SmithVertex Pharmaceuticals Incorpor
2017
Peter PowchikRegeneron Pharmaceuticals
2006
J RamachandranDr Reddys Laboratories Ltd
2016
Marion McCourtRegeneron Pharmaceuticals
2018
Michael PariniVertex Pharmaceuticals Incorpor
2017
Catherine KnuppZoetis
2012
Alejandro BernalZoetis
2015

Entity Summary

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Perrigo Company operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 10600 people.Perrigo Company plc (PRGO) is traded on BATS Exchange in USA and employs 10,600 people.

Perrigo Company Leadership Team

John Hendrickson, President
Gary Cohen, Independent Director
Arthur Shannon, IR Contact Officer
Ronald Winowiecki, Acting CFO
Svend Andersen, Executive Vice President and President - Consumer Healthcare International
Judy Brown, CFO and Executive VP
Laurie Brlas, Independent Director
Donal OConnor, Independent Director
James Michaud, Chief Human Resource Officer, Executive Vice President
Louis Yu, Executive Vice President - Global Quality
John Wesolowski, Executive Vice President and Presidentident - RX
Theodore Samuelsto, Independent Director
Scott Jamison, Executive Vice President General Manager - Nutritionals
Ellen Hoffing, Independent Director
Marc Coucke, Executive Vice President General Manager - Omega Pharma Business
Adriana Karaboutis, Independent Director
Michael Jandernoa, Independent Director
Paul Weninger, Executive Vice President - Global Quality Operations
Thomas Farrington, Senior Vice President CIO
Herman Morris, Independent Director
Jeffrey Needham, Executive Vice President General Manager - Consumer Healthcare
Todd Kingma, Executive VP, General Counsel and Secretary
Rolf Classon, Independent Director
Raymond Silcock, CFO
Shlomo Yanai, Independent Director Nominee
Jatin Shah, Senior Vice President Chief Scientific Officer
Michael Stewart, Senior Vice President - Global Human Resources
Jeffrey Kindler, Independent Director
Jacqualyn Fouse, Independent Director
Grainne Quinn, Executive Vice President Chief Medical Officer
Theodore Samuels, Independent Director
Geoffrey Parker, Independent Director
Murray Kessler, President CEO, Director
Sharon Kochan, Executive VP and General Manager of International
Gary Kunkle, Lead Independent Director
Joseph Papa, Chairman and CEO
Marry Brlas, Independent Chairman of the Board
Bradley Alford, Independent Director
Jeffrey Smith, Independent Director
Bradley Joseph, IR Contact Officer
James Dillard, Executive Vice President Chief Scientific Officer
Douglas Boothe, Executive Vice President General Manager - Rx Pharmaceuticals
Ronald Janish, Executive Vice President - Global Operations and Supply Chain
Uwe Rohrhoff, President CEO, Director

Stock Performance Indicators

Did you try this?

Run Portfolio Volatility Now

   

Portfolio Volatility

Check portfolio volatility and analyze historical return density to properly model market risk
All  Next Launch Module

Currently Active Assets on Macroaxis

GOOG   
Purchased one share of
few hours ago
Traded for 1221.15
UGAZ   
Purchased over 100 shares of
few hours ago
Traded for 19.55
TWTR   
Purchased over 40 shares of
few hours ago
Traded for 43.23
JD   
Purchased over 60 shares of
few hours ago
Traded for 30.83
MDT   
Purchased few shares of
few hours ago
Traded for 111.18
Additionally take a look at Your Equity Center. Please also try Equity Search module to search for activelly-traded equities including funds and etfs from over 30 global markets.
Search macroaxis.com